CLSI eNews - 1 October 2006 (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.

News
Executive Vice President's Message
Automation Alert - Standards in Lab Automation: Enabling Plug and Play
CLSI Supports Lab Quality Assessment Improvements
CLSI Newborn Screening Follow-up Guideline Highlighted at Successful International Society for Neonatal Screening Meeting
Standards Status
Vote and Deadlines
Recently Approved Documents
Call for Nominations
Events and Exhibits
Upcoming Events
CLSI Meetings Calendar
Participate in CLSI
Volunteer
New and Sustaining Members
Update Your Subscription

Recently Approved Documents

Use of External RNA Controls in Gene Expression Assays (MM16-A); Point-of-Care In Vitro Diagnostic (IVD) Testing (POCT4-A2)

Second Notice

MM16-A—Use of External RNA Controls in Gene Expression Assays; Approved Guideline
This document provides protocols supporting the use of external RNA controls in microarray and QRT-PCR-based gene expression experiments, including preparation of control transcripts, design of primers and amplicons, quality control, use in final experimental or clinical test application, and analysis and interpretation of data obtained. A CLSI–IFCC joint project.
Purchase here.

POCT4-A2—Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline – Second Edition
This document provides guidance to users of in vitro diagnostic (IVD) devices outside the clinical laboratory, to ensure reliable results comparable to those obtained within the clinical laboratory. Replaces AST2-A.
Purchase here.

Our procedures have been designed to ensure that consensus has been achieved when a standard or guideline is published at the approved level. This means that a document has been rigorously reviewed by the authoring subcommittee, the area committee overseeing the project, the Board of Directors, and the medical-testing community that participates in the consensus process by carefully reviewing and commenting on the standard or guideline.

You may automatically receive or select approved-level documents as a member benefit. Find out more about joining CLSI: view membership options and benefits.